The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
A team at @bcmhouston, @TexasChildrens, @mcgillu, @pitt_medicine et al explains why a pediatric #Brain tumor (#PFAEpendymoma) affects more boys than girls. @Nature M Taylor, J. Zhang, @ClaudiaKleinman, K.A. Michealraj et al @Nature @Inside_PM
Team at @bcmhouston, @StJudeResearch et al reveals driver of a pediatric #ependymoma, the third most common pediatric #brainTumor. B Deneen, @AlishaKardian @emacalate @BCMNeurosurgery @BCMGradSchool @BCMCancerCenter @TexasChildrens @Nature
12 équipes de recherche de @LDI_ILD ont reçu un financement combiné de plus de 12,9 millions aux concours subventions Projet de l’automne 2025 et Subvention d’équipe : La biologie au service de la prévention du cancer organisés par les @IRSC_CIHR.
12 research teams from the @LDI_ILD were awarded more than $12.9M in combined funding through the Canadian Institutes of Health Research @CIHR_IRSC Fall 2025 Project Grant and Team Grants: Bringing Biology to Cancer Prevention competitions.
#grants #CIHR